Integrin-αvβ3 is a therapeutically targetable fundamental factor in medulloblastoma tumorigenicity and radioresistance
Article in Cancer Research Communications (December 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Cancer Research Communications (December 2023)
Preprint in bioRxiv (March 2023)